2019 HIV & HBV Cure Forum
20 & 21 July 2019 | Mexico City, Mexico
In 2019, the IAS Towards an HIV Cure initiative, in collaboration with the International Coalition to Eliminate Hepatitis B (ICE-HBV), will organize a 1.5 day HIV & HBV Cure Forum on 20 & 21 July 2019, immediately preceding the 10th IAS Conference on HIV Science (IAS 2019).
Following the success of the 2017 HIV Cure & Cancer Forum, the 2019 Forum will focus specifically on the intersection between the scientific efforts in hepatitis B (HBV) and HIV cure research, and seek to merge these two disciplines to accelerate the pace of discovery in cure research for the two fields.
The Forum co-chairs represent an international cohort of experts in the HIV and HBV cure fields:
- Dr. Steven Deeks, Professor of Medicine at the University of California, San Francisco (UCSF), United States
- Prof. Anna Kramvis, Director of the Hepatitis Virus Diversity Research Unit at the University of Witwatersrand, South Africa
- Prof. Sharon Lewin, Director of the Doherty Institute for Infection and Immunity, University of Melbourne, Australia
- Prof. Seng Gee Lim, Director of Hepatology at the National University Health System, Singapore
Forum Objectives
- Accelerate research on similar curative strategies being tested in both domains;
- Create an environment to foster collaborations and merge the HIV cure and HBV cure disciplines;
- Provide an opportunity for the next generation of investigators to launch their careers through interaction and discussion with peers;
- Promote increased investments in cure research;
- Provide a platform for information sharing, debate and network among peers.
- Abstracts
- Registration & Scholarships
- Programme Commitee
We invite you to submit your latest research, specifically on the intersection between the scientific efforts in hepatitis B (HBV) and HIV cure research. Abstracts submitted in any of the following areas will be considered for oral or poster presentation at the HIV & HBV Cure Forum.
- Markers of virus persistence
- Biomarkers of long-term remission or cure
- Role of antivirals in cure
- Therapeutic vaccination strategies
- Role of immune adjuvants
- Gene therapy including siRNA
- Combination cure studies
- Issues in HIV-HBV co-infected individuals
- Social and behavioural sciences
- Capacity building and community engagement
- Global advocacy and impact
To submit an abstract, please use the IAS 2019 abstract submission system, and use the relevant tick box to indicate you would like your abstract to be considered. Deadline for submission is 22 January 2019.
Registration and scholarship applications for the HIV & HBV Cure Forum will open in 2019. Please check this page for updates or sign up to our mailing list here.
The Towards an HIV Cure initiative will sponsor a scholarship programme, aiming to support a number of scholarships to young investigators from both the HIV & HBV cure fields, investigators from resource-limited settings, and community representatives.
Co-chairs
Sharon Lewin, The Peter Doherty Institute for Infection and Immunity, Australia
Steven Deeks, UCSF, United States
Anna Kramvis, University of the Witswatersrand, South Africa
Lim Seng Gee, National University Hospital, Singapore
Members
Jintanat Ananworanich, US Military HIV Research Program, United States
Simani Gaseitsiwe, Botswana Harvard AIDS Institute Partnership & Harvard T.H. Chan School of Public Health, United States
Natalia Laufer, INBIRS Institute UBA-CONICET, Argentina
Wenhui Li, National Institute of Biological Sciences, China
Jake Liang, NIH Intramural Research Program, United States
Mala Maini, University College London, United Kingdom
Richard Njouom, Centre Pasteur du Cameroun, Cameroon
Midnight Poonkasetwattana, APCOM, Thailand
Peter Revill, The Peter Doherty Institute for Infection and Immunity, Australia
Chloe Thio, Johns Hopkins University School of Medicine, United States
Joseph Tucker, UNC at Chapel Hill, United States
Fabien Zoulim, INSERM, France
In collaboration with:
